Dragan Sebisanovic

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

David A. Eberhard, Bruce E. Johnson, Lukas C. Amler et al. · Journal of Clinical Oncology · 2005 · 1.5K citations · Full text

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill et al. · PLoS ONE · 2015 · 708 citations · Full text

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

Oliver A. Zill, Claire Greene, Dragan Sebisanovic et al. · Cancer Discovery · 2015 · 276 citations · Full text

Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms

Joshua S. Kaminker, Yan Zhang, Allison Waugh et al. · Cancer Research · 2007 · 125 citations

Use of the GUARDANT360 noninvasive tumor sequencing assay on 300 patients across colorectal, melanoma, lung, breast, and prostate cancers and its clinical utility.

AmirAli Talasaz, Stefanie Mortimer, Dragan Sebisanovic et al. · Journal of Clinical Oncology · 2014 · 12 citations

Cancer Pathology, Pathology, Tumor Biology +20